Wells Fargo
ENVB icon

Wells Fargo’s Enveric Biosciences ENVB Stock Holding History

Wells Fargo’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2 Hold
1
– – ﹤0.01% 7102
2025
Q4 		$4 Buy
+1
New +$7 ﹤0.01% 6977
2025
Q3 		– Hold
0
– – – 7031
2025
Q2 		– Hold
0
– – – 7056
2025
Q1 		– Hold
0
– – – 6918
2024
Q4 		– Hold
0
– – – 6881
2024
Q3 		– Hold
0
– – – 6702
2024
Q2 		– Hold
0
– – – 6631
2024
Q1 		– Hold
0
– – – 6912
2023
Q4 		– Hold
0
– – – 6963
2023
Q3 		– Hold
0
– – – 6817
2023
Q2 		– Hold
0
– – – 6859
2023
Q1 		– Hold
0
– – – 7114
2022
Q4 		– Hold
0
– – – 6951
2022
Q3 		– Hold
0
– – – 6820
2022
Q2 		– Hold
0
– – – 6967
2022
Q1 		– Hold
0
– – – 7233
2021
Q4 		– Hold
0
– – – 6995
2021
Q3 		– Sell
-1
Closed -$19.4K – 6563
2021
Q2 		$14K Buy
+1
New +$21.4K ﹤0.01% 6032
2021
Q1 		– Hold
0
– – – 6633
2020
Q4 		– Hold
0
– – – 6592
2020
Q3 		– Hold
0
– – – 6447
2020
Q2 		– Hold
0
– – – 6396
2020
Q1 		– Hold
0
– – – 6332
2018
Q1 		– Hold
0
– -$31K – 6415
2017
Q4 		– Hold
0
– – – 5680

Other funds holding ENVB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Wells Fargo's ENVB Position: Q1 2026 in Review

Wells Fargo held its Enveric Biosciences (ENVB) position steady in Q1 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #7102.

Wells Fargo first reported a position in ENVB in Q2 2021 and has held it in 3 quarters since. The position peaked at $14K in Q2 2021. 11 funds tracked by Wall St. Rank hold ENVB as of Q1 2026.

  • Wells Fargo held 1 share of Enveric Biosciences worth $2 as of Q1 2026.
  • Wells Fargo left its Enveric Biosciences share count unchanged in Q1 2026.
  • Enveric Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #7102 holding.
  • Wells Fargo first reported a position in Enveric Biosciences in Q2 2021 and has held it in 3 quarters since.
  • Wells Fargo's Enveric Biosciences position peaked at $14K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Enveric Biosciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.